The global market for Inhaled Nitric Oxide Delivery System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Inhaled Nitric Oxide Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Inhaled Nitric Oxide Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Inhaled Nitric Oxide Delivery System include Mallinckrodt, Santair AE, VERO Biotech, Linde plc, Beyond Air, Inc., SLE, Bellerophon Therapeutics, Air Liquide Healthcare, International Biomedical, Circassia Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide Delivery System.

The Inhaled Nitric Oxide Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhaled Nitric Oxide Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inhaled Nitric Oxide Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inhaled Nitric Oxide Delivery System Market Report

Report Metric	Details
Report Name	Inhaled Nitric Oxide Delivery System Market
Segment by Type	Pediatric Adult
Segment by Application	Hospitals Ambulatory Surgical Centers Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Mallinckrodt, Santair AE, VERO Biotech, Linde plc, Beyond Air, Inc., SLE, Bellerophon Therapeutics, Air Liquide Healthcare, International Biomedical, Circassia Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhaled Nitric Oxide Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhaled Nitric Oxide Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Inhaled Nitric Oxide Delivery System Market report?

Ans: The main players in the Inhaled Nitric Oxide Delivery System Market are Mallinckrodt, Santair AE, VERO Biotech, Linde plc, Beyond Air, Inc., SLE, Bellerophon Therapeutics, Air Liquide Healthcare, International Biomedical, Circassia Pharmaceuticals

What are the Application segmentation covered in the Inhaled Nitric Oxide Delivery System Market report?

Ans: The Applications covered in the Inhaled Nitric Oxide Delivery System Market report are Hospitals, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Inhaled Nitric Oxide Delivery System Market report?

Ans: The Types covered in the Inhaled Nitric Oxide Delivery System Market report are Pediatric, Adult

1 Inhaled Nitric Oxide Delivery System Market Overview

1.1 Product Definition

1.2 Inhaled Nitric Oxide Delivery System by Type

1.2.1 Global Inhaled Nitric Oxide Delivery System Market Value Comparison by Type (2024 VS 2031)

1.2.2 Pediatric

1.2.3 Adult

1.3 Inhaled Nitric Oxide Delivery System by Application

1.3.1 Global Inhaled Nitric Oxide Delivery System Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Global Inhaled Nitric Oxide Delivery System Market Size Estimates and Forecasts

1.4.1 Global Inhaled Nitric Oxide Delivery System Revenue 2020-2031

1.4.2 Global Inhaled Nitric Oxide Delivery System Sales 2020-2031

1.4.3 Global Inhaled Nitric Oxide Delivery System Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Inhaled Nitric Oxide Delivery System Market Competition by Manufacturers

2.1 Global Inhaled Nitric Oxide Delivery System Sales Market Share by Manufacturers (2020-2025)

2.2 Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Inhaled Nitric Oxide Delivery System Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Inhaled Nitric Oxide Delivery System, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Inhaled Nitric Oxide Delivery System, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Inhaled Nitric Oxide Delivery System, Product Type & Application

2.7 Global Key Manufacturers of Inhaled Nitric Oxide Delivery System, Date of Enter into This Industry

2.8 Global Inhaled Nitric Oxide Delivery System Market Competitive Situation and Trends

2.8.1 Global Inhaled Nitric Oxide Delivery System Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Inhaled Nitric Oxide Delivery System Players Market Share by Revenue

2.8.3 Global Inhaled Nitric Oxide Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Inhaled Nitric Oxide Delivery System Market Scenario by Region

3.1 Global Inhaled Nitric Oxide Delivery System Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Inhaled Nitric Oxide Delivery System Sales by Region: 2020-2031

3.2.1 Global Inhaled Nitric Oxide Delivery System Sales by Region: 2020-2025

3.2.2 Global Inhaled Nitric Oxide Delivery System Sales by Region: 2026-2031

3.3 Global Inhaled Nitric Oxide Delivery System Revenue by Region: 2020-2031

3.3.1 Global Inhaled Nitric Oxide Delivery System Revenue by Region: 2020-2025

3.3.2 Global Inhaled Nitric Oxide Delivery System Revenue by Region: 2026-2031

3.4 North America Inhaled Nitric Oxide Delivery System Market Facts & Figures by Country

3.4.1 North America Inhaled Nitric Oxide Delivery System Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Inhaled Nitric Oxide Delivery System Sales by Country (2020-2031)

3.4.3 North America Inhaled Nitric Oxide Delivery System Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Inhaled Nitric Oxide Delivery System Market Facts & Figures by Country

3.5.1 Europe Inhaled Nitric Oxide Delivery System Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Inhaled Nitric Oxide Delivery System Sales by Country (2020-2031)

3.5.3 Europe Inhaled Nitric Oxide Delivery System Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Inhaled Nitric Oxide Delivery System Market Facts & Figures by Region

3.6.1 Asia Pacific Inhaled Nitric Oxide Delivery System Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Inhaled Nitric Oxide Delivery System Sales by Region (2020-2031)

3.6.3 Asia Pacific Inhaled Nitric Oxide Delivery System Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Inhaled Nitric Oxide Delivery System Market Facts & Figures by Country

3.7.1 Latin America Inhaled Nitric Oxide Delivery System Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Inhaled Nitric Oxide Delivery System Sales by Country (2020-2031)

3.7.3 Latin America Inhaled Nitric Oxide Delivery System Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Inhaled Nitric Oxide Delivery System Market Facts & Figures by Country

3.8.1 Middle East and Africa Inhaled Nitric Oxide Delivery System Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Inhaled Nitric Oxide Delivery System Sales by Country (2020-2031)

3.8.3 Middle East and Africa Inhaled Nitric Oxide Delivery System Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Inhaled Nitric Oxide Delivery System Sales by Type (2020-2031)

4.1.1 Global Inhaled Nitric Oxide Delivery System Sales by Type (2020-2025)

4.1.2 Global Inhaled Nitric Oxide Delivery System Sales by Type (2026-2031)

4.1.3 Global Inhaled Nitric Oxide Delivery System Sales Market Share by Type (2020-2031)

4.2 Global Inhaled Nitric Oxide Delivery System Revenue by Type (2020-2031)

4.2.1 Global Inhaled Nitric Oxide Delivery System Revenue by Type (2020-2025)

4.2.2 Global Inhaled Nitric Oxide Delivery System Revenue by Type (2026-2031)

4.2.3 Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Type (2020-2031)

4.3 Global Inhaled Nitric Oxide Delivery System Price by Type (2020-2031)

5 Segment by Application

5.1 Global Inhaled Nitric Oxide Delivery System Sales by Application (2020-2031)

5.1.1 Global Inhaled Nitric Oxide Delivery System Sales by Application (2020-2025)

5.1.2 Global Inhaled Nitric Oxide Delivery System Sales by Application (2026-2031)

5.1.3 Global Inhaled Nitric Oxide Delivery System Sales Market Share by Application (2020-2031)

5.2 Global Inhaled Nitric Oxide Delivery System Revenue by Application (2020-2031)

5.2.1 Global Inhaled Nitric Oxide Delivery System Revenue by Application (2020-2025)

5.2.2 Global Inhaled Nitric Oxide Delivery System Revenue by Application (2026-2031)

5.2.3 Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Application (2020-2031)

5.3 Global Inhaled Nitric Oxide Delivery System Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Mallinckrodt

6.1.1 Mallinckrodt Company Information

6.1.2 Mallinckrodt Description and Business Overview

6.1.3 Mallinckrodt Inhaled Nitric Oxide Delivery System Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Mallinckrodt Inhaled Nitric Oxide Delivery System Product Portfolio

6.1.5 Mallinckrodt Recent Developments/Updates

6.2 Santair AE

6.2.1 Santair AE Company Information

6.2.2 Santair AE Description and Business Overview

6.2.3 Santair AE Inhaled Nitric Oxide Delivery System Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Santair AE Inhaled Nitric Oxide Delivery System Product Portfolio

6.2.5 Santair AE Recent Developments/Updates

6.3 VERO Biotech

6.3.1 VERO Biotech Company Information

6.3.2 VERO Biotech Description and Business Overview

6.3.3 VERO Biotech Inhaled Nitric Oxide Delivery System Sales, Revenue and Gross Margin (2020-2025)

6.3.4 VERO Biotech Inhaled Nitric Oxide Delivery System Product Portfolio

6.3.5 VERO Biotech Recent Developments/Updates

6.4 Linde plc

6.4.1 Linde plc Company Information

6.4.2 Linde plc Description and Business Overview

6.4.3 Linde plc Inhaled Nitric Oxide Delivery System Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Linde plc Inhaled Nitric Oxide Delivery System Product Portfolio

6.4.5 Linde plc Recent Developments/Updates

6.5 Beyond Air, Inc.

6.5.1 Beyond Air, Inc. Company Information

6.5.2 Beyond Air, Inc. Description and Business Overview

6.5.3 Beyond Air, Inc. Inhaled Nitric Oxide Delivery System Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Beyond Air, Inc. Inhaled Nitric Oxide Delivery System Product Portfolio

6.5.5 Beyond Air, Inc. Recent Developments/Updates

6.6 SLE

6.6.1 SLE Company Information

6.6.2 SLE Description and Business Overview

6.6.3 SLE Inhaled Nitric Oxide Delivery System Sales, Revenue and Gross Margin (2020-2025)

6.6.4 SLE Inhaled Nitric Oxide Delivery System Product Portfolio

6.6.5 SLE Recent Developments/Updates

6.7 Bellerophon Therapeutics

6.7.1 Bellerophon Therapeutics Company Information

6.7.2 Bellerophon Therapeutics Description and Business Overview

6.7.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery System Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery System Product Portfolio

6.7.5 Bellerophon Therapeutics Recent Developments/Updates

6.8 Air Liquide Healthcare

6.8.1 Air Liquide Healthcare Company Information

6.8.2 Air Liquide Healthcare Description and Business Overview

6.8.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery System Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Air Liquide Healthcare Inhaled Nitric Oxide Delivery System Product Portfolio

6.8.5 Air Liquide Healthcare Recent Developments/Updates

6.9 International Biomedical

6.9.1 International Biomedical Company Information

6.9.2 International Biomedical Description and Business Overview

6.9.3 International Biomedical Inhaled Nitric Oxide Delivery System Sales, Revenue and Gross Margin (2020-2025)

6.9.4 International Biomedical Inhaled Nitric Oxide Delivery System Product Portfolio

6.9.5 International Biomedical Recent Developments/Updates

6.10 Circassia Pharmaceuticals

6.10.1 Circassia Pharmaceuticals Company Information

6.10.2 Circassia Pharmaceuticals Description and Business Overview

6.10.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery System Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery System Product Portfolio

6.10.5 Circassia Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Inhaled Nitric Oxide Delivery System Industry Chain Analysis

7.2 Inhaled Nitric Oxide Delivery System Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Inhaled Nitric Oxide Delivery System Production Mode & Process Analysis

7.4 Inhaled Nitric Oxide Delivery System Sales and Marketing

7.4.1 Inhaled Nitric Oxide Delivery System Sales Channels

7.4.2 Inhaled Nitric Oxide Delivery System Distributors

7.5 Inhaled Nitric Oxide Delivery System Customer Analysis

8 Inhaled Nitric Oxide Delivery System Market Dynamics

8.1 Inhaled Nitric Oxide Delivery System Industry Trends

8.2 Inhaled Nitric Oxide Delivery System Market Drivers

8.3 Inhaled Nitric Oxide Delivery System Market Challenges

8.4 Inhaled Nitric Oxide Delivery System Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bellerophon Therapeutics

Air Liquide Healthcare

International Biomedical

Circassia Pharmaceuticals

Santair AE

Beyond Air, Inc.

List of Tables

Table 1. Global Inhaled Nitric Oxide Delivery System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Inhaled Nitric Oxide Delivery System Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Inhaled Nitric Oxide Delivery System Market Competitive Situation by Manufacturers in 2024

Table 4. Global Inhaled Nitric Oxide Delivery System Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Inhaled Nitric Oxide Delivery System Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Inhaled Nitric Oxide Delivery System Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Inhaled Nitric Oxide Delivery System Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Inhaled Nitric Oxide Delivery System, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Inhaled Nitric Oxide Delivery System, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Inhaled Nitric Oxide Delivery System, Product Type & Application

Table 12. Global Key Manufacturers of Inhaled Nitric Oxide Delivery System, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Inhaled Nitric Oxide Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide Delivery System as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Inhaled Nitric Oxide Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Inhaled Nitric Oxide Delivery System Sales by Region (2020-2025) & (K Units)

Table 18. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Region (2020-2025)

Table 19. Global Inhaled Nitric Oxide Delivery System Sales by Region (2026-2031) & (K Units)

Table 20. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Region (2026-2031)

Table 21. Global Inhaled Nitric Oxide Delivery System Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Region (2020-2025)

Table 23. Global Inhaled Nitric Oxide Delivery System Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Region (2026-2031)

Table 25. North America Inhaled Nitric Oxide Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Inhaled Nitric Oxide Delivery System Sales by Country (2020-2025) & (K Units)

Table 27. North America Inhaled Nitric Oxide Delivery System Sales by Country (2026-2031) & (K Units)

Table 28. North America Inhaled Nitric Oxide Delivery System Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Inhaled Nitric Oxide Delivery System Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Inhaled Nitric Oxide Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Inhaled Nitric Oxide Delivery System Sales by Country (2020-2025) & (K Units)

Table 32. Europe Inhaled Nitric Oxide Delivery System Sales by Country (2026-2031) & (K Units)

Table 33. Europe Inhaled Nitric Oxide Delivery System Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Inhaled Nitric Oxide Delivery System Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Inhaled Nitric Oxide Delivery System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Inhaled Nitric Oxide Delivery System Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Inhaled Nitric Oxide Delivery System Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Inhaled Nitric Oxide Delivery System Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Inhaled Nitric Oxide Delivery System Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Inhaled Nitric Oxide Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Inhaled Nitric Oxide Delivery System Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Inhaled Nitric Oxide Delivery System Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Inhaled Nitric Oxide Delivery System Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Inhaled Nitric Oxide Delivery System Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Inhaled Nitric Oxide Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Inhaled Nitric Oxide Delivery System Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Inhaled Nitric Oxide Delivery System Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Inhaled Nitric Oxide Delivery System Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Inhaled Nitric Oxide Delivery System Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Inhaled Nitric Oxide Delivery System Sales (K Units) by Type (2020-2025)

Table 51. Global Inhaled Nitric Oxide Delivery System Sales (K Units) by Type (2026-2031)

Table 52. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Type (2020-2025)

Table 53. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Type (2026-2031)

Table 54. Global Inhaled Nitric Oxide Delivery System Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Inhaled Nitric Oxide Delivery System Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Type (2020-2025)

Table 57. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Type (2026-2031)

Table 58. Global Inhaled Nitric Oxide Delivery System Price (US$/Unit) by Type (2020-2025)

Table 59. Global Inhaled Nitric Oxide Delivery System Price (US$/Unit) by Type (2026-2031)

Table 60. Global Inhaled Nitric Oxide Delivery System Sales (K Units) by Application (2020-2025)

Table 61. Global Inhaled Nitric Oxide Delivery System Sales (K Units) by Application (2026-2031)

Table 62. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Application (2020-2025)

Table 63. Global Inhaled Nitric Oxide Delivery System Sales Market Share by Application (2026-2031)

Table 64. Global Inhaled Nitric Oxide Delivery System Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Inhaled Nitric Oxide Delivery System Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Application (2020-2025)

Table 67. Global Inhaled Nitric Oxide Delivery System Revenue Market Share by Application (2026-2031)

Table 68. Global Inhaled Nitric Oxide Delivery System Price (US$/Unit) by Application (2020-2025)

Table 69. Global Inhaled Nitric Oxide Delivery System Price (US$/Unit) by Application (2026-2031)

Table 70. Mallinckrodt Company Information

Table 71. Mallinckrodt Description and Business Overview

Table 72. Mallinckrodt Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Mallinckrodt Inhaled Nitric Oxide Delivery System Product

Table 74. Mallinckrodt Recent Developments/Updates

Table 75. Santair AE Company Information

Table 76. Santair AE Description and Business Overview

Table 77. Santair AE Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Santair AE Inhaled Nitric Oxide Delivery System Product

Table 79. Santair AE Recent Developments/Updates

Table 80. VERO Biotech Company Information

Table 81. VERO Biotech Description and Business Overview

Table 82. VERO Biotech Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. VERO Biotech Inhaled Nitric Oxide Delivery System Product

Table 84. VERO Biotech Recent Developments/Updates

Table 85. Linde plc Company Information

Table 86. Linde plc Description and Business Overview

Table 87. Linde plc Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Linde plc Inhaled Nitric Oxide Delivery System Product

Table 89. Linde plc Recent Developments/Updates

Table 90. Beyond Air, Inc. Company Information

Table 91. Beyond Air, Inc. Description and Business Overview

Table 92. Beyond Air, Inc. Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Beyond Air, Inc. Inhaled Nitric Oxide Delivery System Product

Table 94. Beyond Air, Inc. Recent Developments/Updates

Table 95. SLE Company Information

Table 96. SLE Description and Business Overview

Table 97. SLE Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. SLE Inhaled Nitric Oxide Delivery System Product

Table 99. SLE Recent Developments/Updates

Table 100. Bellerophon Therapeutics Company Information

Table 101. Bellerophon Therapeutics Description and Business Overview

Table 102. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery System Product

Table 104. Bellerophon Therapeutics Recent Developments/Updates

Table 105. Air Liquide Healthcare Company Information

Table 106. Air Liquide Healthcare Description and Business Overview

Table 107. Air Liquide Healthcare Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Air Liquide Healthcare Inhaled Nitric Oxide Delivery System Product

Table 109. Air Liquide Healthcare Recent Developments/Updates

Table 110. International Biomedical Company Information

Table 111. International Biomedical Description and Business Overview

Table 112. International Biomedical Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. International Biomedical Inhaled Nitric Oxide Delivery System Product

Table 114. International Biomedical Recent Developments/Updates

Table 115. Circassia Pharmaceuticals Company Information

Table 116. Circassia Pharmaceuticals Description and Business Overview

Table 117. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery System Product

Table 119. Circassia Pharmaceuticals Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Inhaled Nitric Oxide Delivery System Distributors List

Table 123. Inhaled Nitric Oxide Delivery System Customers List

Table 124. Inhaled Nitric Oxide Delivery System Market Trends

Table 125. Inhaled Nitric Oxide Delivery System Market Drivers

Table 126. Inhaled Nitric Oxide Delivery System Market Challenges

Table 127. Inhaled Nitric Oxide Delivery System Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Inhaled Nitric Oxide Delivery System

Figure 2. Global Inhaled Nitric Oxide Delivery System Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Inhaled Nitric Oxide Delivery System Market Share by Type: 2024 & 2031

Figure 4. Pediatric Product Picture

Figure 5. Adult Product Picture

Figure 6. Global Inhaled Nitric Oxide Delivery System Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Inhaled Nitric Oxide Delivery System Market Share by Application: 2024 & 2031

Figure 8. Hospitals

Figure 9. Ambulatory Surgical Centers

Figure 10. Others

Figure 11. Global Inhaled Nitric Oxide Delivery System Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Inhaled Nitric Oxide Delivery System Market Size (2020-2031) & (US$ Million)

Figure 13. Global Inhaled Nitric Oxide Delivery System Sales (2020-2031) & (K Units)

Figure 14. Global Inhaled Nitric Oxide Delivery System Average Price (US$/Unit) & (2020-2031)

Figure 15. Inhaled Nitric Oxide Delivery System Report Years Considered

Figure 16. Inhaled Nitric Oxide Delivery System Sales Share by Manufacturers in 2024

Figure 17. Global Inhaled Nitric Oxide Delivery System Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Inhaled Nitric Oxide Delivery System Players: Market Share by Revenue in Inhaled Nitric Oxide Delivery System in 2024

Figure 19. Inhaled Nitric Oxide Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Inhaled Nitric Oxide Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Inhaled Nitric Oxide Delivery System Sales Market Share by Country (2020-2031)

Figure 22. North America Inhaled Nitric Oxide Delivery System Revenue Market Share by Country (2020-2031)

Figure 23. United States Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Inhaled Nitric Oxide Delivery System Sales Market Share by Country (2020-2031)

Figure 26. Europe Inhaled Nitric Oxide Delivery System Revenue Market Share by Country (2020-2031)

Figure 27. Germany Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Inhaled Nitric Oxide Delivery System Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Inhaled Nitric Oxide Delivery System Revenue Market Share by Region (2020-2031)

Figure 34. China Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Inhaled Nitric Oxide Delivery System Sales Market Share by Country (2020-2031)

Figure 42. Latin America Inhaled Nitric Oxide Delivery System Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa Inhaled Nitric Oxide Delivery System Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa Inhaled Nitric Oxide Delivery System Revenue Market Share by Country (2020-2031)

Figure 48. Turkey Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE Inhaled Nitric Oxide Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of Inhaled Nitric Oxide Delivery System by Type (2020-2031)

Figure 52. Global Revenue Market Share of Inhaled Nitric Oxide Delivery System by Type (2020-2031)

Figure 53. Global Inhaled Nitric Oxide Delivery System Price (US$/Unit) by Type (2020-2031)

Figure 54. Global Sales Market Share of Inhaled Nitric Oxide Delivery System by Application (2020-2031)

Figure 55. Global Revenue Market Share of Inhaled Nitric Oxide Delivery System by Application (2020-2031)

Figure 56. Global Inhaled Nitric Oxide Delivery System Price (US$/Unit) by Application (2020-2031)

Figure 57. Inhaled Nitric Oxide Delivery System Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions